Ocimum Biosolutions, a leading provider of Innovative Bioinformatics solutions and Laboratory Information Management System (LIMS), has licensed Genowiz to Bioniche Therapeutics Research Centre of Bioniche Life Sciences Inc and University of Ottawa, Canada. The financial details of the deal are not disclosed.

Bioniche is a premiere biopharmaceutical company committed to sustain and advance the clinical development of its drug discovery programme. The University of Ottawa houses one of the most active biological research labs. "We expect that Genowiz will meet their requirements and also increase their research work in the field of microarrays," Anuradha Acharya, CEO, Ocimum Biosolutions stated.

Genowiz is a powerful gene expression analysis programme that has been designed to store, process and visualize gene expression data efficiently. It includes a suite of advanced analysis methods and offers choice for selecting analysis that is appropriate to a researcher's dataset. It provides numerous visualization options to track down intricate correlation in microarray data.

Bioniche Life Sciences Inc is a Canadian biopharmaceutical company that discovers, develops, manufactures, and markets proprietary products for human and animal health markets worldwide. The Human Health Division consists of two Units: Bioniche Therapeutics and Bioniche Pharma.

Biology programme at the University of Ottawa is designed to provide a solid background for agriculture, forestry, environmental sciences, resource management, medicine, paramedical services, education etc.

Ocimum Biosolutions is an ISO 9001:2000 certified life sciences contract R&D Company that provides customized contract research services and bioinformatics tools & services in the area of genomics, proteomics and laboratory information management (LIMS) for Biotech and Pharmaceutical industry. Ocimum's Indian arm is located at Hyderabad.